335 results in Exploration of Targeted Anti-tumor Therapy
Latest
  • Latest
  • Most Viewed
  • Most Downloaded
  • Most Cited
Sort by :
Open Access Review
Genetic and epigenetic landscape of O6-methylguanine-DNA methyltransferase (MGMT): implications for DNA repair and cancer therapeutics
Shishir Singh ... Atar Singh Kushwah
Published: August 28, 2025 Explor Target Antitumor Ther. 2025;6:1002335
This article belongs to the special issue Advances in Cancer Genomics and Therapeutic Targets
135 14 0
Open Access Review
Inflammatory signatures across four photon radiotherapy and proton radiotherapy: mechanisms, mitigation, and quality of life impact
Yuting Sheng ... Yujiang Fang
Published: August 28, 2025 Explor Target Antitumor Ther. 2025;6:1002334
115 13 0
Open Access Review
Improvement of the sensitivity of circulating tumor DNA-based liquid biopsy: current approaches and future perspectives
Ekaterina S. Kuligina ... Evgeny N. Imyanitov
Published: August 08, 2025 Explor Target Antitumor Ther. 2025;6:1002333
697 27 0
Open Access Original Article
Anti-angiogenic effects of Moringa oleifera silver nanoparticles on endothelial cells: in vitro and ex vivo studies
Rolla Al-Shalabi ... Nozlena Abdul Samad
Published: July 27, 2025 Explor Target Antitumor Ther. 2025;6:1002332
1039 32 0
Open Access Original Article
Novel kinase-activating genetic events in non-small cell lung carcinomas
Elena V. Preobrazhenskaya ... Evgeny N. Imyanitov
Published: July 09, 2025 Explor Target Antitumor Ther. 2025;6:1002330
611 11 0
Open Access Review
Dysbiosis and colorectal cancer: conducive factors, biological and molecular role, and therapeutic prospectives
Gurkaranjot Singh ... Vikrant Rai
Published: June 27, 2025 Explor Target Antitumor Ther. 2025;6:1002329
1207 23 2
Open Access Review
Biliary tract cancers: advances in diagnostic and management
James Gutmans, Hiba Mechahougui
Published: June 23, 2025 Explor Target Antitumor Ther. 2025;6:1002328
990 25 0
Open Access Perspective
Future perspectives: targeting fibroblast growth factor receptor 1 to enhance the efficacy of immunotherapy
Ilya Tsimafeyeu
Published: June 20, 2025 Explor Target Antitumor Ther. 2025;6:1002327
2978 47 0
Open Access Review
An overview of the feasibility of nanomedicine in pancreatic cancer theranostics
Kyriakos Kokkinogoulis ... Mersini Makropoulou
Published: June 18, 2025 Explor Target Antitumor Ther. 2025;6:1002326
960 13 0
Open Access Original Article
Comparison of outcomes of neoadjuvant chemotherapy in BRCA1- versus BRCA2-associated breast and ovarian cancers
Anna Sokolenko ... Evgeny Imyanitov
Published: June 18, 2025 Explor Target Antitumor Ther. 2025;6:1002325
702 7 0
Open Access Review
Osteosarcoma: current insights and advances
Guraustin S. Brar ... Yujiang Fang
Published: June 15, 2025 Explor Target Antitumor Ther. 2025;6:1002324
1015 31 1
Open Access Original Article
Mutational landscape of epidermoid carcinoma of the penis in a Brazilian cohort
Renato Mendes Rossi De Lucca ... Rodolfo Borges dos Reis
Published: June 06, 2025 Explor Target Antitumor Ther. 2025;6:1002323
840 11 0
Open Access Review
Role of exosomes in transforming growth factor-β-mediated cancer cell plasticity and drug resistance
Tatiana Ruksha, Nadezhda Palkina
Published: June 05, 2025 Explor Target Antitumor Ther. 2025;6:1002322
807 15 0
Open Access Review
Circulating tumor cells: overcoming challenges of detecting a needle in a haystack
Zhuldyz Myrkhiyeva ... Aliya Bekmurzayeva
Published: May 29, 2025 Explor Target Antitumor Ther. 2025;6:1002321
1240 24 0
Open Access Original Article
A viral circular RNA in Kaposi’s sarcoma-associated herpesvirus modulates viral and host gene expression during latent and lytic replication
Soleil Torres ... Rolf Renne
Published: May 29, 2025 Explor Target Antitumor Ther. 2025;6:1002320
This article belongs to the special issue Potential of Non-Coding RNAs in Cancer Research and Treatment
944 11 1
Open Access Review
The DNA methylation landscape of musculoskeletal sarcomas
Mariana Chantre-Justino, Walter Meohas
Published: May 26, 2025 Explor Target Antitumor Ther. 2025;6:1002319
803 14 0
Open Access Original Article
Prognostic impact of biomarkers in PMBCL: rationale for early integration of immune checkpoint inhibitors
Yana K. Mangasarova ... Andrey B. Sudarikov
Published: May 20, 2025 Explor Target Antitumor Ther. 2025;6:1002318
This article belongs to the special issue Immune Checkpoint Therapy and Biomarkers in Cancer
1025 21 0
Open Access Commentary
The role of circulating tumor DNA (ctDNA) in urothelial cancers
Jeanny B. Aragon-Ching
Published: May 19, 2025 Explor Target Antitumor Ther. 2025;6:1002317
857 20 0
Open Access Systematic Review
Utility of CA-125 for diagnosis and prognosis of breast cancer: a systematic review
Zohre Momenimovahed ... Ibrahim Alkatout
Published: May 15, 2025 Explor Target Antitumor Ther. 2025;6:1002316
2277 18 0